Amneal Pharmaceuticals (AMRX) Other Gross PP&E Adjustments: 2017-2025
Historic Other Gross PP&E Adjustments for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Sep 2025 value amounting to -$54.4 million.
- Amneal Pharmaceuticals' Other Gross PP&E Adjustments rose 49.53% to -$54.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $749.2 million, marking a year-over-year increase of 58.43%. This contributed to the annual value of $914.7 million for FY2024, which is 1.90% up from last year.
- Per Amneal Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$54.4 million for Q3 2025, which was up 1.18% from -$55.1 million recorded in Q2 2025.
- In the past 5 years, Amneal Pharmaceuticals' Other Gross PP&E Adjustments ranged from a high of $914.7 million in Q4 2024 and a low of -$192.6 million during Q1 2021.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$101.2 million (2023), whereas its average is $72.2 million.
- As far as peak fluctuations go, Amneal Pharmaceuticals' Other Gross PP&E Adjustments dropped by 6.59% in 2024, and later soared by 68.73% in 2025.
- Quarterly analysis of 5 years shows Amneal Pharmaceuticals' Other Gross PP&E Adjustments stood at $842.8 million in 2021, then increased by 1.32% to $853.9 million in 2022, then increased by 5.12% to $897.6 million in 2023, then rose by 1.90% to $914.7 million in 2024, then soared by 49.53% to -$54.4 million in 2025.
- Its last three reported values are -$54.4 million in Q3 2025, -$55.1 million for Q2 2025, and -$56.0 million during Q1 2025.